![]()
15
| 1 | 2005
Klinisk Biokemi i Norden
16. Anand I.S, Fisher LD, Chiang YT, Latini R,
Masson S, Maggioni AP, Glazer RD, Tognoni G,
Cohn JN. Changes in brain natriuretic peptide
and norepinephrine over time and mortality and
morbidity in the Valsartan Heart Failure Trial
(Val-HeFT), Circulation2003; 107:1278–1283
17. Gackowski A, Isnard R, Golmard J-L, et al.
Comparison of echocardiography and plasma
B-type natriuretic peptide for monitoring the
response to treatment in acute heart failure Eur
Heart J 2004;25:1788-1796
18. Ambrosi P, Oddoze C, Riberi A, Arques S,
Portugal H, Metras D, Habib G. Usefulness of
N-terminal-pro-brain natriuretic peptide levels
in predicting survival in heart transplant recipi-
ents. Am J Cardiol. 2004 ;94(12):1585-7.
19. de Lemos, J.A., Morrow, D.A., Bentley, J.H.,
Omland, T., Sabatine, M.S., McCabe, C.H., Hall,
C., Cannon, C.P. and Braunwald, E. The prog-
nosis value of B-type natriuretic peptide in
patients with acute coronary syndromes. N Engl
J Med 2001;345: 1014–1021.
20. Richards AM, Nicholls MG, Espiner EA,
Lainchbury JG, Troughton RW, Elliott J,
Frampton C, Turner J, Crozier IG, Yandle TG.
B-type natriuretic peptides and ejection frac-
tion for prognosis after myocardial infarction.
Circulation. 2003;107(22):2786-92
21. Omland T, Richards AM, Wergeland R, Vik-Mo
H. B-type natriuretic peptide and long-term
survival in patients with stable coronary artery
disease. Am J Cardiol. 2005;95(1):24-8
22. Kragelund C, Gronning B, Kober L, Hildebrandt
P, Steffensen R. N-terminal pro-B-type natri-
uretic peptide and long-term mortality in sta-
ble coronary heart disease. N Engl J Med.
2005;352(7):666-75.
23. Conraads VM., Beckers P, Vaes J, Martin M,
Van Hoof V, De Maeyer C, Possemiers N, Wuyts
FL, Vrints C.J. Combined endurance/resistance
training reduces NT-proBNP levels in patients
with chronic heart failure. Eur. Heart J; 2004;
25(20): 1797 – 1805.
24. Troughton RW, Frampton C.M, Yandle TG,
Espiner EA, Nicholls MG, Richards AM.,
Treatment of heart failure guided by plasma
aminoterminal brain natriuretic peptide (N-BNP)
concentrations, Lancet 2000;355:1126–1130.
25. Munagala VK, Burnett JC Jr, Redfield MM. The
natriuretic peptides in cardiovascular medicine
Curr Probl Cardiol. 2004;29(12):707-69.
26. Harrison A, Bhalla V, Gardetto N, Maisel A.S..
Evolving Use of B-Type Natriuretic Peptide in
Clinical Practice Clin Chem. 2004; 50(9): 1714
- 1715.
